• Results
  • Access planning: Do pharma companies plan ahead to ensure thei...
Access planning

Do pharma companies plan ahead to ensure their products are accessible to patients in low- and middle-income countries?

New medicines, vaccines and other life-saving products must be made rapidly available in low- and middle-income countries as soon as they have been approved for sale. This requires tactical planning throughout the research and development process. 

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Get in touch

Back to top |